By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Lejrvej 37-41

Værløse    DK-3500  Denmark
Phone: 45-44-47-80-80 Fax: 45-44-47-24-25



Company News
Egalet Announces Issuance Of U.S. Patents Covering Guardian™ Technology And Product Candidates 9/11/2014 7:54:39 AM
Egalet To Present Data From Abuse-Deterrence Studies At PAINWeek 2014 In Las Vegas 9/4/2014 10:11:29 AM
Egalet Announces Successful End-Of-Phase 2 Meeting With The FDA For Egalet-002 8/18/2014 7:04:46 AM
Egalet Reports Second Quarter 2014 Financial Results And Provides Business Update 8/12/2014 9:02:36 AM
Egalet Announces Topline Results From Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001 8/6/2014 7:33:13 AM
Egalet To Present At The Canaccord Genuity Growth Conference On August 13 7/30/2014 10:52:18 AM
Egalet To Host Conference Call And Webcast To Discuss Second Quarter Financial Results On August 12, 2014 7/29/2014 9:20:07 AM
Egalet Appoints Jeffrey M. Dayno, M.D. As Chief Medical Officer 7/28/2014 8:52:03 AM
Egalet Reports Positive Top-Line Results From Category 1 Abuse Deterrence Studies Demonstrating Egalet-001 Resists Physical And Chemical Manipulation 7/15/2014 7:27:30 AM
Egalet To Present At Upcoming Investor Conferences In June 5/22/2014 9:31:03 AM